Trials / Completed
CompletedNCT01159925
Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children
Epidemiologic Surveillance to Assess Trends in Acute Hepatitis A Among Children in Panama
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 42 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 1 Month – 15 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect epidemiological and clinical data to assess the vaccine impact and occurrence of confirmed acute hepatitis A cases in sentinel hospitals after the introduction of Havrix™ into the Expanded Program of Immunization.
Detailed description
This is an observational, prospective, multi-centre, sentinel based study in 3 hospitals in Panama. Hospitals are selected based on population density or hepatitis A disease burden. The Pan American Health Organization (PAHO) definition for a possible case of acute hepatitis A are used for subjects aged between \>1 month and \<15 years. Data regarding clinical and epidemiologic information are collected and serum samples are collected to test hepatitis A markers and determine if infection with hepatitis A virus has recently occurred. Surveillance will be for a period of approximately 2.5 years from the date of study initiation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Serum sample | Serum samples collected |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2010-07-12
- Last updated
- 2012-11-22
Locations
1 site across 1 country: Panama
Source: ClinicalTrials.gov record NCT01159925. Inclusion in this directory is not an endorsement.